United States Pediatric Medicines Market Report 2017

August 2017 | 108 pages | ID: U8A3F525B53EN
QYResearch

Abstracts

In this report, the United States Pediatric Medicines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Pediatric Medicines in these regions, from 2012 to 2022 (forecast).

United States Pediatric Medicines market competition by top manufacturers/players, with Pediatric Medicines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• GSK
• Novartis
• Pfizer
• Sanofi
• Abbott
• Bristol-Myers Squibb
• Cipla
• Eisai Pharmaceuticals
• Eli Lilly
• F.Hoffman-La Roche
• Glenmark
• Helsinn Healthcare

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Enteral
• Parenteral
• Topical

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Pediatric Medicines for each application, including

• 0-6months
• 6-12months
• 12-24months
• More than 24 months

Contents

United States Pediatric Medicines Market Report 2017

1 PEDIATRIC MEDICINES OVERVIEW

1.1 Product Overview and Scope of Pediatric Medicines
1.2 Classification of Pediatric Medicines by Product Category
  1.2.1 United States Pediatric Medicines Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Pediatric Medicines Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Enteral
  1.2.4 Parenteral
  1.2.5 Topical
1.3 United States Pediatric Medicines Market by Application/End Users
  1.3.1 United States Pediatric Medicines Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 0-6months
  1.3.3 6-12months
  1.3.4 12-24months
  1.3.5 More than 24 months
1.4 United States Pediatric Medicines Market by Region
  1.4.1 United States Pediatric Medicines Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Pediatric Medicines Status and Prospect (2012-2022)
  1.4.3 Southwest Pediatric Medicines Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Pediatric Medicines Status and Prospect (2012-2022)
  1.4.5 New England Pediatric Medicines Status and Prospect (2012-2022)
  1.4.6 The South Pediatric Medicines Status and Prospect (2012-2022)
  1.4.7 The Midwest Pediatric Medicines Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Pediatric Medicines (2012-2022)
  1.5.1 United States Pediatric Medicines Sales and Growth Rate (2012-2022)
  1.5.2 United States Pediatric Medicines Revenue and Growth Rate (2012-2022)

2 UNITED STATES PEDIATRIC MEDICINES MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Pediatric Medicines Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Pediatric Medicines Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Pediatric Medicines Average Price by Players/Suppliers (2012-2017)
2.4 United States Pediatric Medicines Market Competitive Situation and Trends
  2.4.1 United States Pediatric Medicines Market Concentration Rate
  2.4.2 United States Pediatric Medicines Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Pediatric Medicines Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES PEDIATRIC MEDICINES SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Pediatric Medicines Sales and Market Share by Region (2012-2017)
3.2 United States Pediatric Medicines Revenue and Market Share by Region (2012-2017)
3.3 United States Pediatric Medicines Price by Region (2012-2017)

4 UNITED STATES PEDIATRIC MEDICINES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Pediatric Medicines Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Pediatric Medicines Revenue and Market Share by Type (2012-2017)
4.3 United States Pediatric Medicines Price by Type (2012-2017)
4.4 United States Pediatric Medicines Sales Growth Rate by Type (2012-2017)

5 UNITED STATES PEDIATRIC MEDICINES SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Pediatric Medicines Sales and Market Share by Application (2012-2017)
5.2 United States Pediatric Medicines Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES PEDIATRIC MEDICINES PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 GSK
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Pediatric Medicines Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 GSK Pediatric Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Novartis
  6.2.2 Pediatric Medicines Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Novartis Pediatric Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Pfizer
  6.3.2 Pediatric Medicines Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Pfizer Pediatric Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Sanofi
  6.4.2 Pediatric Medicines Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Sanofi Pediatric Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Abbott
  6.5.2 Pediatric Medicines Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Abbott Pediatric Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Bristol-Myers Squibb
  6.6.2 Pediatric Medicines Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Bristol-Myers Squibb Pediatric Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Cipla
  6.7.2 Pediatric Medicines Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Cipla Pediatric Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Eisai Pharmaceuticals
  6.8.2 Pediatric Medicines Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Eisai Pharmaceuticals Pediatric Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Eli Lilly
  6.9.2 Pediatric Medicines Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Eli Lilly Pediatric Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 F.Hoffman-La Roche
  6.10.2 Pediatric Medicines Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 F.Hoffman-La Roche Pediatric Medicines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Glenmark
6.12 Helsinn Healthcare

7 PEDIATRIC MEDICINES MANUFACTURING COST ANALYSIS

7.1 Pediatric Medicines Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Pediatric Medicines

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Pediatric Medicines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Pediatric Medicines Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES PEDIATRIC MEDICINES MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Pediatric Medicines Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Pediatric Medicines Sales Volume Forecast by Type (2017-2022)
11.3 United States Pediatric Medicines Sales Volume Forecast by Application (2017-2022)
11.4 United States Pediatric Medicines Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Pediatric Medicines
Figure United States Pediatric Medicines Market Size (K Units) by Type (2012-2022)
Figure United States Pediatric Medicines Sales Volume Market Share by Type (Product Category) in 2016
Figure Enteral Product Picture
Figure Parenteral Product Picture
Figure Topical Product Picture
Figure United States Pediatric Medicines Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Pediatric Medicines by Application in 2016
Figure 0-6months Examples
Figure 6-12months Examples
Figure 12-24months Examples
Figure More than 24 months Examples
Figure United States Pediatric Medicines Market Size (Million USD) by Region (2012-2022)
Figure The West Pediatric Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Pediatric Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Pediatric Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Pediatric Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Pediatric Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Pediatric Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Pediatric Medicines Sales (K Units) and Growth Rate (2012-2022)
Figure United States Pediatric Medicines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Pediatric Medicines Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Pediatric Medicines Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Pediatric Medicines Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Pediatric Medicines Sales Share by Players/Suppliers
Figure 2017 United States Pediatric Medicines Sales Share by Players/Suppliers
Figure United States Pediatric Medicines Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Pediatric Medicines Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Pediatric Medicines Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Pediatric Medicines Revenue Share by Players/Suppliers
Figure 2017 United States Pediatric Medicines Revenue Share by Players/Suppliers
Table United States Market Pediatric Medicines Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Pediatric Medicines Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Pediatric Medicines Market Share of Top 3 Players/Suppliers
Figure United States Pediatric Medicines Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Pediatric Medicines Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Pediatric Medicines Product Category
Table United States Pediatric Medicines Sales (K Units) by Region (2012-2017)
Table United States Pediatric Medicines Sales Share by Region (2012-2017)
Figure United States Pediatric Medicines Sales Share by Region (2012-2017)
Figure United States Pediatric Medicines Sales Market Share by Region in 2016
Table United States Pediatric Medicines Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Pediatric Medicines Revenue Share by Region (2012-2017)
Figure United States Pediatric Medicines Revenue Market Share by Region (2012-2017)
Figure United States Pediatric Medicines Revenue Market Share by Region in 2016
Table United States Pediatric Medicines Price (USD/Unit) by Region (2012-2017)
Table United States Pediatric Medicines Sales (K Units) by Type (2012-2017)
Table United States Pediatric Medicines Sales Share by Type (2012-2017)
Figure United States Pediatric Medicines Sales Share by Type (2012-2017)
Figure United States Pediatric Medicines Sales Market Share by Type in 2016
Table United States Pediatric Medicines Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Pediatric Medicines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Pediatric Medicines by Type (2012-2017)
Figure Revenue Market Share of Pediatric Medicines by Type in 2016
Table United States Pediatric Medicines Price (USD/Unit) by Types (2012-2017)
Figure United States Pediatric Medicines Sales Growth Rate by Type (2012-2017)
Table United States Pediatric Medicines Sales (K Units) by Application (2012-2017)
Table United States Pediatric Medicines Sales Market Share by Application (2012-2017)
Figure United States Pediatric Medicines Sales Market Share by Application (2012-2017)
Figure United States Pediatric Medicines Sales Market Share by Application in 2016
Table United States Pediatric Medicines Sales Growth Rate by Application (2012-2017)
Figure United States Pediatric Medicines Sales Growth Rate by Application (2012-2017)
Table GSK Basic Information List
Table GSK Pediatric Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GSK Pediatric Medicines Sales Growth Rate (2012-2017)
Figure GSK Pediatric Medicines Sales Market Share in United States (2012-2017)
Figure GSK Pediatric Medicines Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Pediatric Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Pediatric Medicines Sales Growth Rate (2012-2017)
Figure Novartis Pediatric Medicines Sales Market Share in United States (2012-2017)
Figure Novartis Pediatric Medicines Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Pediatric Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Pediatric Medicines Sales Growth Rate (2012-2017)
Figure Pfizer Pediatric Medicines Sales Market Share in United States (2012-2017)
Figure Pfizer Pediatric Medicines Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Pediatric Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Pediatric Medicines Sales Growth Rate (2012-2017)
Figure Sanofi Pediatric Medicines Sales Market Share in United States (2012-2017)
Figure Sanofi Pediatric Medicines Revenue Market Share in United States (2012-2017)
Table Abbott Basic Information List
Table Abbott Pediatric Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Pediatric Medicines Sales Growth Rate (2012-2017)
Figure Abbott Pediatric Medicines Sales Market Share in United States (2012-2017)
Figure Abbott Pediatric Medicines Revenue Market Share in United States (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Pediatric Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Pediatric Medicines Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Pediatric Medicines Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Pediatric Medicines Revenue Market Share in United States (2012-2017)
Table Cipla Basic Information List
Table Cipla Pediatric Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cipla Pediatric Medicines Sales Growth Rate (2012-2017)
Figure Cipla Pediatric Medicines Sales Market Share in United States (2012-2017)
Figure Cipla Pediatric Medicines Revenue Market Share in United States (2012-2017)
Table Eisai Pharmaceuticals Basic Information List
Table Eisai Pharmaceuticals Pediatric Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eisai Pharmaceuticals Pediatric Medicines Sales Growth Rate (2012-2017)
Figure Eisai Pharmaceuticals Pediatric Medicines Sales Market Share in United States (2012-2017)
Figure Eisai Pharmaceuticals Pediatric Medicines Revenue Market Share in United States (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Pediatric Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly Pediatric Medicines Sales Growth Rate (2012-2017)
Figure Eli Lilly Pediatric Medicines Sales Market Share in United States (2012-2017)
Figure Eli Lilly Pediatric Medicines Revenue Market Share in United States (2012-2017)
Table F.Hoffman-La Roche Basic Information List
Table F.Hoffman-La Roche Pediatric Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure F.Hoffman-La Roche Pediatric Medicines Sales Growth Rate (2012-2017)
Figure F.Hoffman-La Roche Pediatric Medicines Sales Market Share in United States (2012-2017)
Figure F.Hoffman-La Roche Pediatric Medicines Revenue Market Share in United States (2012-2017)
Table Glenmark Basic Information List
Table Helsinn Healthcare Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pediatric Medicines
Figure Manufacturing Process Analysis of Pediatric Medicines
Figure Pediatric Medicines Industrial Chain Analysis
Table Raw Materials Sources of Pediatric Medicines Major Players/Suppliers in 2016
Table Major Buyers of Pediatric Medicines
Table Distributors/Traders List
Figure United States Pediatric Medicines Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Pediatric Medicines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Pediatric Medicines Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Pediatric Medicines Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Pediatric Medicines Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Pediatric Medicines Sales Volume (K Units) Forecast by Type in 2022
Table United States Pediatric Medicines Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Pediatric Medicines Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Pediatric Medicines Sales Volume (K Units) Forecast by Application in 2022
Table United States Pediatric Medicines Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Pediatric Medicines Sales Volume Share Forecast by Region (2017-2022)
Figure United States Pediatric Medicines Sales Volume Share Forecast by Region (2017-2022)
Figure United States Pediatric Medicines Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources